CTRI/2012/09/002948已完成4 期
Safety and Effectiveness of Dexmedetomidine for sedation during awake nasal fibreoptic intubation ? A prospective, randomized, double blind study
Kasturba Hospital KMC Manipal0 个研究点目标入组 36 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients between 18-85 years undergoing awake nasal fibreoptic intubation
排除标准
- •ASA physical status IV
- •Raised intracranial pressure
- •Uncontrolled seizure disorder and/or known psychiatric illness
- •Current (in the past 14 days) treatment with an α2 agonist or antagonist
- •Patients in whom dexmedetomidine or benzodiazepine administration is contra-indicated
- •Patients with acute unstable angina, laboratory confirmed acute myocardial infarction within the past 6 weeks, heart rate < 50 bpm, systolic blood pressure (SBP) < 90 mmHg, or complete heart block unless they have a pacemaker
- •Patients with elevated SGPT (ALT) and/or SGOT (AST) values of > 2 times the upper limit of normal.
研究者
相似试验
已完成
不适用
Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventionsISRCTN68599804Academic Medical Centre (AMC) (Netherlands)64
已完成
3 期
Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX)NL-OMON35831Academisch Medisch Centrum64
尚未招募
Unknown
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgeryCTRI/2024/07/070582Dr Sridevi Mulimani
已完成
不适用
To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTPCTRI/2017/11/010353ALL INDIA INSTITUTE OF MEDICAL SCIENCES80
进行中（未招募）
1 期
EFFECTIVENESS OF INTRANASAL DEXMEDETOMIDINE FOR SEDATEDAUDITORY BRAINSTEM RESPONSE TESTINGChild requiring auditory evaluation in a context of suspicion of deafness, language delay, overall developmental delay, risk factors for hearing loss.MedDRA version: 20.1Level: PTClassification code 10049507Term: Brain stem auditory evoked responseSystem Organ Class: 10022891 - InvestigationsEUCTR2018-001466-42-FRFondation Lenval - Hôpitaux Pédiatriques de Nice CHULENVA60